Selected research
Industry Research
Acute Kidney Injury Drugs Industry Research Report 2026
Market perspective
The global Acute Kidney Injury Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Acute Kidney Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Acute Kidney Injury Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Acute Kidney Injury Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Acute Kidney Injury Drugs include Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Quark Pharmaceuticals, Baxter International, LG Chem, Asahi Kasei Medical and Angion Biomedica Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Acute Kidney Injury Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Acute Kidney Injury Drugs Market by Company
Fresenius Medical Care AG & Co. KGaA
B. Braun Melsungen AG
Quark Pharmaceuticals
Baxter International
LG Chem
Asahi Kasei Medical
Angion Biomedica Corp
Acute Kidney Injury Drugs Segment by Type
Intrinsic Acute Kidney Injury
Postrenal Acute Kidney Injury
Prerenal Acute Kidney Injury
Others
Acute Kidney Injury Drugs Segment by Application
Hospital
Clinic
Acute Kidney Injury Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Kidney Injury Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acute Kidney Injury Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Kidney Injury Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Acute Kidney Injury Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Acute Kidney Injury Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Acute Kidney Injury Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intrinsic Acute Kidney Injury
- Postrenal Acute Kidney Injury
- Prerenal Acute Kidney Injury
- Others
Applications
- Hospital
- Clinic
Companies covered
- Fresenius Medical Care AG & Co. KGaA
- B. Braun Melsungen AG
- Quark Pharmaceuticals
- Baxter International
- LG Chem
- Asahi Kasei Medical
- Angion Biomedica Corp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Acute Kidney Injury Drugs Market Size (2021-2032)
- 2.2.2 Global Acute Kidney Injury Drugs Sales (2021-2032)
- 2.2.3 Global Acute Kidney Injury Drugs Market Average Price (2021-2032)
- 2.3 Acute Kidney Injury Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Intrinsic Acute Kidney Injury
- 2.3.3 Postrenal Acute Kidney Injury
- 2.3.4 Prerenal Acute Kidney Injury
- 2.3.5 Others
- 2.4 Acute Kidney Injury Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Acute Kidney Injury Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Acute Kidney Injury Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Acute Kidney Injury Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Acute Kidney Injury Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Acute Kidney Injury Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Acute Kidney Injury Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Acute Kidney Injury Drugs, Product Type & Application
- 3.8 Global Manufacturers of Acute Kidney Injury Drugs, Established Date
- 3.9 Global Acute Kidney Injury Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Fresenius Medical Care AG & Co. KGaA
- 4.1.1 Fresenius Medical Care AG & Co. KGaA Company Information
- 4.1.2 Fresenius Medical Care AG & Co. KGaA Business Overview
- 4.1.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolio
- 4.1.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
- 4.2 B. Braun Melsungen AG
- 4.2.1 B. Braun Melsungen AG Company Information
- 4.2.2 B. Braun Melsungen AG Business Overview
- 4.2.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolio
- 4.2.5 B. Braun Melsungen AG Recent Developments
- 4.3 Quark Pharmaceuticals
- 4.3.1 Quark Pharmaceuticals Company Information
- 4.3.2 Quark Pharmaceuticals Business Overview
- 4.3.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolio
- 4.3.5 Quark Pharmaceuticals Recent Developments
- 4.4 Baxter International
- 4.4.1 Baxter International Company Information
- 4.4.2 Baxter International Business Overview
- 4.4.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baxter International Acute Kidney Injury Drugs Product Portfolio
- 4.4.5 Baxter International Recent Developments
- 4.5 LG Chem
- 4.5.1 LG Chem Company Information
- 4.5.2 LG Chem Business Overview
- 4.5.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LG Chem Acute Kidney Injury Drugs Product Portfolio
- 4.5.5 LG Chem Recent Developments
- 4.6 Asahi Kasei Medical
- 4.6.1 Asahi Kasei Medical Company Information
- 4.6.2 Asahi Kasei Medical Business Overview
- 4.6.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolio
- 4.6.5 Asahi Kasei Medical Recent Developments
- 4.7 Angion Biomedica Corp
- 4.7.1 Angion Biomedica Corp Company Information
- 4.7.2 Angion Biomedica Corp Business Overview
- 4.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolio
- 4.7.5 Angion Biomedica Corp Recent Developments
5 Global Acute Kidney Injury Drugs Market Scenario by Region
- 5.1 Global Acute Kidney Injury Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Acute Kidney Injury Drugs Sales by Region: 2021-2032
- 5.2.1 Global Acute Kidney Injury Drugs Sales by Region: 2021-2026
- 5.2.2 Global Acute Kidney Injury Drugs Sales by Region: 2027-2032
- 5.3 Global Acute Kidney Injury Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Acute Kidney Injury Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Acute Kidney Injury Drugs Revenue by Region: 2027-2032
- 5.4 North America Acute Kidney Injury Drugs Market Facts & Figures by Country
- 5.4.1 North America Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Acute Kidney Injury Drugs Sales by Country (2021-2032)
- 5.4.3 North America Acute Kidney Injury Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Acute Kidney Injury Drugs Market Facts & Figures by Country
- 5.5.1 Europe Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Acute Kidney Injury Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Acute Kidney Injury Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Acute Kidney Injury Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Acute Kidney Injury Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Acute Kidney Injury Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Acute Kidney Injury Drugs Market Facts & Figures by Country
- 5.7.1 South America Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Acute Kidney Injury Drugs Sales by Country (2021-2032)
- 5.7.3 South America Acute Kidney Injury Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Acute Kidney Injury Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Acute Kidney Injury Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Acute Kidney Injury Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Acute Kidney Injury Drugs Sales by Type (2021-2032)
- 6.1.1 Global Acute Kidney Injury Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Acute Kidney Injury Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Acute Kidney Injury Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Acute Kidney Injury Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Acute Kidney Injury Drugs Sales by Application (2021-2032)
- 7.1.1 Global Acute Kidney Injury Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Acute Kidney Injury Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Acute Kidney Injury Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Acute Kidney Injury Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Acute Kidney Injury Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Acute Kidney Injury Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Acute Kidney Injury Drugs Value Chain Analysis
- 8.1.1 Acute Kidney Injury Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Acute Kidney Injury Drugs Production Mode & Process
- 8.2 Acute Kidney Injury Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Acute Kidney Injury Drugs Distributors
- 8.2.3 Acute Kidney Injury Drugs Customers
9 Global Acute Kidney Injury Drugs Analyzing Market Dynamics
- 9.1 Acute Kidney Injury Drugs Industry Trends
- 9.2 Acute Kidney Injury Drugs Industry Drivers
- 9.3 Acute Kidney Injury Drugs Industry Opportunities and Challenges
- 9.4 Acute Kidney Injury Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst